This inventor holds 1 USPTO granted patent and 1 published patent application and 1 EPO patent. Top assignees: Fondazione Italiana Sclerosi Multipla—fism Onlus, Universita′ Degli Studi Di Milano. Active years: 2018.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 1 
1 out of 40 Years Active: 2018
Title: Paola Zaratin: Innovator in Neurodegenerative Disease Treatment
Introduction
Paola Zaratin is a prominent inventor based in Genoa, Italy. She has made significant contributions to the field of neurodegenerative diseases through her innovative research and development of chemical compounds.
Latest Patents
Zaratin holds a patent for GPR17 receptor modulators. This patent involves chemical compounds that act on GPR17 receptors, which are useful in the treatment or amelioration of chronic and/or acute neurodegenerative diseases. These include conditions such as multiple sclerosis, inflammatory diseases, pathologies involving the immune system, cardiovascular diseases, and renal diseases. She has successfully developed a solution that addresses critical health challenges.
Career Highlights
Throughout her career, Paola Zaratin has worked with esteemed institutions, including Università Degli Studi Di Milano and Fondazione Italiana Sclerosi Multipla—FISM Onlus. Her work has been instrumental in advancing the understanding and treatment of neurodegenerative conditions.
Collaborations
Zaratin has collaborated with notable colleagues, including Maria Pia Abbracchio and Mario Alberto Battaglia. These partnerships have enhanced her research and contributed to the development of effective treatments.
Conclusion
Paola Zaratin's innovative work in the field of neurodegenerative diseases highlights her commitment to improving health outcomes. Her contributions through patents and collaborations continue to pave the way for advancements in medical science.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile